All terms in GO
| Label | Id | Description |
|---|---|---|
| protein import into peroxisome matrix, substrate release | GO_0044721 | [The process by which the cargo protein is released into the peroxisomal matrix, following translocation across the membrane.] |
| cellular protein complex disassembly | GO_0043624 | [The disaggregation of a protein complex into its constituent components, occurring at the level of an individual cell. Protein complexes may have other associated non-protein prosthetic groups, such as nucleic acids, metal ions or carbohydrate groups.] |
| protein import into peroxisome matrix | GO_0016558 | [The import of proteins into the peroxisomal matrix. A peroxisome targeting signal (PTS) binds to a soluble receptor protein in the cytosol, and the resulting complex then binds to a receptor protein in the peroxisome membrane and is imported. The cargo protein is then released into the peroxisome matrix.] |
| NEDD8 transferase activity | GO_0019788 | [Catalysis of the transfer of NEDD8 from one protein to another via the reaction X-NEDD8 + Y --> Y-NEDD8 + X, where both X-NEDD8 and Y-NEDD8 are covalent linkages.] |
| SUMO transferase activity | GO_0019789 | [Catalysis of the transfer of SUMO from one protein to another via the reaction X-SUMO + Y --> Y-SUMO + X, where both X-SUMO and Y-SUMO are covalent linkages.] |
| protein sumoylation | GO_0016925 | [The process in which a SUMO protein (small ubiquitin-related modifier) is conjugated to a target protein via an isopeptide bond between the carboxy-terminus of SUMO with an epsilon-amino group of a lysine residue of the target protein.] |
| interleukin-1, type I receptor binding | GO_0005150 | [Interacting selectively and non-covalently with a Type I interleukin-1 receptor.] |
| interleukin-1, type II receptor binding | GO_0005151 | [Interacting selectively and non-covalently with a Type II interleukin-1 receptor.] |
| interleukin-1 receptor antagonist activity | GO_0005152 | [Blocks the binding of interleukin-1 to the interleukin-1 receptor complex.] |
| receptor antagonist activity | GO_0048019 | [The activity of a gene product that interacts with a receptor to decrease the ability of the receptor agonist to bind and activate the receptor.] |
| interleukin-1 binding | GO_0019966 | [Interacting selectively and non-covalently with interleukin-1.] |
| negative regulation of cytokine-mediated signaling pathway | GO_0001960 | [Any process that stops, prevents, or reduces the frequency, rate or extent of the cytokine mediated signaling pathway.] |
| interleukin-8 receptor binding | GO_0005153 | [Interacting selectively and non-covalently with the interleukin-8 receptor.] |
| CXCR chemokine receptor binding | GO_0045236 | [Interacting selectively and non-covalently with a chemokine receptor in the CXCR family.] |
| epidermal growth factor receptor binding | GO_0005154 | [Interacting selectively and non-covalently with the epidermal growth factor receptor.] |
| HLA-C specific inhibitory MHC class I receptor activity | GO_0030110 | [Combining with a MHC class I molecule of the HLA-C subclass to mediate signaling that inhibits activation of a lymphocyte.] |
| inhibitory MHC class I receptor activity | GO_0032396 | [Combining with a MHC class I protein complex to mediate signaling that inhibits activation of a lymphocyte.] |
| obsolete epidermal growth factor receptor activating ligand activity | GO_0005155 | [OBSOLETE. This term was not defined before being made obsolete.] |
| regulation of Wnt signaling pathway | GO_0030111 | [Any process that modulates the frequency, rate or extent of the activity of the Wnt signal transduction pathway.] |
| regulation of signal transduction | GO_0009966 | [Any process that modulates the frequency, rate or extent of signal transduction.] |